Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/cd/7b/ef/cd7bef13-2f6c-ec7c-5332-0d014ca9308b/mza_2534052509331663784.jpg/600x600bb.jpg
MedtronicTalks
Tom Salemi
47 episodes
2 months ago
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management. Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the Medtronic Podcast. Subscribe to this podcast on every major podcast platform.
Show more...
Technology
RSS
All content for MedtronicTalks is the property of Tom Salemi and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management. Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the Medtronic Podcast. Subscribe to this podcast on every major podcast platform.
Show more...
Technology
https://i1.sndcdn.com/artworks-p5Pz54iAOmVNCT6f-HhyBTw-t3000x3000.jpg
Medtronic Labs’ Ruchika Singhal says one thing can bring better healthcare to more people worldwide
MedtronicTalks
36 minutes 47 seconds
3 years ago
Medtronic Labs’ Ruchika Singhal says one thing can bring better healthcare to more people worldwide
Ruchika Singhal, president of Medtronic Labs, says she grew up in Medtronic, starting her career as an engineer. But her professional life really began when she took over Medtronic Labs, a non-profit quasi-independent arm with a mission of bringing better healthcare to more people worldwide. In this podcast, Singhal shares her story and identifies the one thing that will help more people living away from big cities and healthcare hubs. “We’re never going to have enough doctors and we’re never going to have enough infrastructure,” Singhal says. “Technology is the solution.” Medtronic Labs is working to leverage technology to help people battle the biggest threat – non communicable diseases like diabetes which can be managed with proper care. This episode is sponsored by AcuityMD. Go to AcuityMD.com for more information.
MedtronicTalks
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management. Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the Medtronic Podcast. Subscribe to this podcast on every major podcast platform.